医薬品用ゼラチン市場：供給源、タイプ、機能、用途別-2025-2030年世界予測

医薬品用ゼラチン市場は、2023年に12億米ドルと評価され、2024年には12億8,000万米ドルに達すると予測され、CAGR 6.44%で成長し、2030年には18億6,000万米ドルになると予測されています。

医薬品用ゼラチンは、主にカプセルの殻や錠剤の製剤化、様々な医薬品の安定剤として使用される重要な賦形剤です。その必要性は、生体適合性と急速に溶解する能力に起因しており、人体へのドラッグデリバリーに理想的です。ゼラチンの最も一般的な用途は、ソフトジェルカプセル、ハードカプセル、代用血漿です。最終用途分野は主に、経口、眼科、局所デリバリーシステムを製造する製薬会社です。

医薬品用ゼラチン市場は、摂取のしやすさと生物学的利用能の向上によるカプセル需要の高まりの影響を大きく受けています。非伝染性疾患の急増に加え、老人人口の増加がゼラチン需要を押し上げています。ドラッグ・デリバリー・システムの改善を重視する規制当局の動きは、この分野の技術革新をさらに後押ししています。特に、菜食主義の傾向の高まりと動物愛護に関する消費者の意識の高まりにより、市場は植物由来の代替ゼラチンの開発機会に直面しています。企業は、新規で持続可能なゼラチン製剤の研究開発に投資することで、これを活用することができます。地理的には、アジア太平洋の新興市場、特に中国とインドは、医療インフラの拡大と医薬品に対する消費支出の増加により、大きな可能性を秘めています。

しかし、厳しい規制基準や原料価格の変動、特に牛海綿状脳症（BSE）のような疾病の発生による牛や豚の調達など、市場は制約に直面しています。課題は、コスト、品質、適正製造基準（GMP）などの国際基準の遵守のバランスをとることにあります。

革新的な分野としては、機械的特性と安定性の分子制御を強化するバイオエンジニアリング・ゼラチンや、カスタマイズされたドラッグ・デリバリー・システムにおけるゼラチンの利用があります。さらに、製薬会社と研究機関との共同研究イニシアチブにより、革新的な製品用途や製剤が生まれる可能性があります。市場は俊敏性を要求しており、企業は競争力を維持するために技術の進歩や消費者の嗜好の進化に同調する必要があります。

市場力学：急速に進化する医薬品用ゼラチン市場の主要市場インサイトを公開

医薬品用ゼラチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 医薬用ゼラチンの大規模使用
  • 慢性疾患および感染症の流行
  • 臨床試験および予備的な薬剤研究の増加
• 市場抑制要因
  • 医薬品用ゼラチンに関連する高コスト
• 市場機会
  • ワクチンやドラッグデリバリーにおけるゼラチンナノ粒子の最近の進歩
  • サプライチェーンと流通網の改善
• 市場の課題
  • 医薬品用ゼラチンの安全性と品質に関する懸念

ポーターの5つの力：医薬品用ゼラチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、医薬品用ゼラチン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品用ゼラチン市場における外部からの影響の把握

外部マクロ環境要因は、医薬品用ゼラチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品用ゼラチン市場における競合情勢の把握

医薬品用ゼラチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品用ゼラチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品用ゼラチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品用ゼラチン市場における成功への道筋を描く

医薬品用ゼラチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の投薬におけるゼラチンの大規模使用
    • 慢性疾患および感染症の有病率
    • 臨床試験と予備的な薬物研究の増加
  • 抑制要因
    • 医薬品用ゼラチンに関連する高コスト
  • 機会
    • ワクチンとドラッグデリバリーにおけるゼラチンナノ粒子の最近の進歩
    • サプライチェーンと流通ネットワークの改善
  • 課題
    • 医薬品用ゼラチンの安全性と品質に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品用ゼラチン市場：ソース別

• 牛骨
• 牛皮
• 海洋
• 豚肉
• 家禽

第7章 医薬品用ゼラチン市場：タイプ別

• タイプA
• タイプB

第8章 医薬品用ゼラチン市場：機能別

• ゲル化剤
• 安定剤
• 増粘剤

第9章 医薬品用ゼラチン市場：用途別

• 吸収性止血材
• ハードカプセル
• ソフトカプセル
• タブレット

第10章 南北アメリカの医薬品用ゼラチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の医薬品用ゼラチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの医薬品用ゼラチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Gelco International
• Gelita AG
• Gelnex
• Geltec Private Limited
• Geltech Co. Ltd.
• Henan Boom Gelatin Co. Ltd.
• India Gelatine & Chemicals Ltd.
• Italgel S.r.l.
• Junca Gelatines SL
• Kenney & Ross Limited
• Lapi Gelatine S.p.A
• SAS Gelatines Weishardt
• Tessenderlo Group NV
• Toudongbao Biotechnology Co., Ltd.
• Xiamen Gelken Gelatin Co., Ltd.

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL GELATIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL GELATIN MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY MARINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GELLING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY STABILIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ABSORBABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023

The Pharmaceutical Gelatin Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.44%, to USD 1.86 billion by 2030.

Pharmaceutical gelatin is a critical excipient used primarily in the formulation of capsule shells, tablets, and as a stabilizer in various medicinal products. Its necessity stems from its biocompatibility and ability to dissolve rapidly, making it ideal for drug delivery in the human body. Gelatin's most common applications are in soft gel capsules, hard capsules, and blood plasma substitutes. End-use sectors primarily include pharmaceutical companies manufacturing oral, ophthalmic, and topical delivery systems.

The market for pharmaceutical gelatin is significantly influenced by the rising demand for capsules due to their ease of consumption and improved bioavailability. An increasing geriatric population, alongside the surging occurrence of non-communicable diseases, boosts gelatin demand. Regulatory bodies' emphasis on improving drug delivery systems further fuels innovation in this sector. Notably, the market faces opportunities in developing plant-based gelatin alternatives, driven by a growing veganism trend and rising consumer awareness regarding animal welfare. Companies can capitalize on this by investing in R&D toward novel, sustainable gelatin formulations. Geographically, emerging markets in Asia-Pacific, particularly China and India, offer vast potential due to expanding healthcare infrastructure and rising consumer spending on pharmaceuticals.

However, the market confronts limitations, including stringent regulatory norms and volatility in raw material prices, especially concerning bovine and porcine sourcing due to disease outbreaks like Bovine Spongiform Encephalopathy (BSE). The challenge lies in balancing cost, quality, and compliance with international standards such as Good Manufacturing Practices (GMP).

Innovative areas include bio-engineered gelatin, which enhances molecular control over mechanical properties and stability, and gelatin's utilization in customized drug delivery systems. Moreover, collaborative research initiatives between pharmaceutical companies and research institutions may yield innovative product applications and formulations. The market demands agility, requiring firms to synchronize with technological advancements and evolving consumer preferences to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Large scale use of gelatin in pharma drug dosage
  • Prevalence of chronic and infectious disorders
  • Increasing clinical trials and preliminary drug studies
• Market Restraints
  • High cost associated with Pharmaceutical Gelatin
• Market Opportunities
  • Recent advancements in gelatin nanoparticle in vaccine and drug delivery
  • Improvements in supply chain and distribution network
• Market Challenges
  • Safety and quality concerns with pharmaceutical gelatin

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Gelatin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Gelatin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Gelatin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Gelatin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Gelatin Market

A detailed market share analysis in the Pharmaceutical Gelatin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Gelatin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Gelatin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Gelatin Market

A strategic analysis of the Pharmaceutical Gelatin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Gelatin Market, highlighting leading vendors and their innovative profiles. These include Gelco International, Gelita AG, Gelnex, Geltec Private Limited, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgel S.r.l., Junca Gelatines SL, Kenney & Ross Limited, Lapi Gelatine S.p.A, SAS Gelatines Weishardt, Tessenderlo Group NV, Toudongbao Biotechnology Co., Ltd., and Xiamen Gelken Gelatin Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Gelatin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Source, market is studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry.
• Based on Type, market is studied across Type A and Type B.
• Based on Function, market is studied across Gelling Agents, Stabilizing Agents, and Thickening Agents.
• Based on Application, market is studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Large scale use of gelatin in pharma drug dosage
    • 5.1.1.2. Prevalence of chronic and infectious disorders
    • 5.1.1.3. Increasing clinical trials and preliminary drug studies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with Pharmaceutical Gelatin
  • 5.1.3. Opportunities
    • 5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
    • 5.1.3.2. Improvements in supply chain and distribution network
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Gelatin Market, by Source

• 6.1. Introduction
• 6.2. Bovine Bone
• 6.3. Bovine Skin
• 6.4. Marine
• 6.5. Porcine
• 6.6. Poultry

7. Pharmaceutical Gelatin Market, by Type

• 7.1. Introduction
• 7.2. Type A
• 7.3. Type B

8. Pharmaceutical Gelatin Market, by Function

• 8.1. Introduction
• 8.2. Gelling Agents
• 8.3. Stabilizing Agents
• 8.4. Thickening Agents

9. Pharmaceutical Gelatin Market, by Application

• 9.1. Introduction
• 9.2. Absorbable Hemostats
• 9.3. Hard Capsules
• 9.4. Soft Capsules
• 9.5. Tablets

10. Americas Pharmaceutical Gelatin Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmaceutical Gelatin Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Gelatin Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Gelco International
• 2. Gelita AG
• 3. Gelnex
• 4. Geltec Private Limited
• 5. Geltech Co. Ltd.
• 6. Henan Boom Gelatin Co. Ltd.
• 7. India Gelatine & Chemicals Ltd.
• 8. Italgel S.r.l.
• 9. Junca Gelatines SL
• 10. Kenney & Ross Limited
• 11. Lapi Gelatine S.p.A
• 12. SAS Gelatines Weishardt
• 13. Tessenderlo Group NV
• 14. Toudongbao Biotechnology Co., Ltd.
• 15. Xiamen Gelken Gelatin Co., Ltd.